Gene therapy offers to beat hepatitis B virus by muting its DNA
An experimental therapy called CRMA-1001 is a remarkable development because, instead of targeting the virus directly, it silences the viral DNA; this is promising because current treatments rarely eliminate the DNA, which allows the virus to rebound
Read original article on The Hindu: Latest News today from India and the World, Breaking news, Top Headlines and Trending News Videos. →Related news
-
Rupee Rises 7 Paise to 95.19 Against US Dollar in Early Trade
Economy
Markets
India
-
Prasidh Krishna ruled out of New Zealand ODI series, Siraj joins India A squad
Sports
Cricket
India
-
Markets extend previous session's rally amid buying in IT firms, earnings-driven demand in Trent
Economy
Markets
India
-
Tech firms take fresh hit as earnings misses fan AI fears
Technology
AI
-
BJP's Abhay Patel Mocks Rahul Gandhi Over Congress' 4-0 Defeat in Karnataka MLC Polls
Politics
Elections
India
-
Prasidh Krishna ruled out of New Zealand ODI series; Siraj added to India A squad for 2nd game
Sports
Cricket
India
-
Countdown progressing for ISRO's crucial GSLV-F18 launch carrying navigation satellite NVS-03
Science
Space
India
-
Tamil Nadu Assembly: The changing address of power
Politics
Government
India